These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1405603)
81. Improved survival with adjuvant immunotherapy after surgical resection in a murine model. Hamby LS; Freeman JW; McGrath PC Ann Surg Oncol; 1994 Jul; 1(4):307-13. PubMed ID: 7850529 [TBL] [Abstract][Full Text] [Related]
82. Anti-tumor effect of tumor necrosis factor combined with electrotherapy on mouse sarcoma. Sersa G; Golouh R; Miklavcic D Anticancer Drugs; 1994 Feb; 5(1):69-74. PubMed ID: 8186433 [TBL] [Abstract][Full Text] [Related]
83. DNA cytometric and histologic findings in mouse tumors (BP and S 180) with different response to treatment with tumor necrosis factor. Rychly J; Knippel E; Krygier-Stojalowska A; Nizze H; Kuchnio M; Kraeft SK Acta Oncol; 1990; 29(1):47-51. PubMed ID: 2310603 [TBL] [Abstract][Full Text] [Related]
84. Immunothermotherapy and related TNS induction in mice. Kuwabara M J Vet Med Sci; 1993 Jun; 55(3):471-3. PubMed ID: 8357924 [TBL] [Abstract][Full Text] [Related]
86. Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells. Aruga A; Shu S; Chang AE Cancer Immunol Immunother; 1995 Nov; 41(5):317-24. PubMed ID: 8536278 [TBL] [Abstract][Full Text] [Related]
87. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors. Chou T; Bertera S; Chang AE; Shu S J Immunol; 1988 Sep; 141(5):1775-81. PubMed ID: 3261761 [TBL] [Abstract][Full Text] [Related]
88. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma. Sakai K; Chang AE; Shu SY Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215 [TBL] [Abstract][Full Text] [Related]
89. Effect of interleukin-1 alpha on the in vitro activation of tumor-draining lymph node cells for adoptive immunotherapy. Hammel JM; Tuck MK; Hain JM; Chang AE; Sondak VK J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):1-12. PubMed ID: 8081555 [TBL] [Abstract][Full Text] [Related]
90. Divergent effects of TNF alpha in the adoptive immunotherapy of a murine sarcoma. Wagner PD; Shu S; Chang AE J Surg Res; 1992 Aug; 53(2):152-7. PubMed ID: 1405603 [TBL] [Abstract][Full Text] [Related]